The prognostic importance of miR-21 in stage II colon cancer: A population-based study

British Journal of Cancer

Volumn 107, Issue 7, 2012, Pages 1169-1174

  Kjaer Frifeldt, S ^a,b   Hansen, T F ^a   Nielsen, B S ^c   Joergensen, S ^c   Lindebjerg, J ^a   Soerensen, F B ^a,b   Depont Christensen, R ^b   Jakobsen, A ^a,b  

^a LILLEBAELT HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Exiqon AS   (Denmark)

Author keywords

colon cancer; miRNA 21; population study; prognostic marker; stage II

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA 21;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE CANCER SPECIFIC SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLONIC NEOPLASMS; DENMARK; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS;

EID: 84866863598     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.365     Document Type: Article

References (30)

1. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136
2. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzo M, Garcia-Foncillas J (2006) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29
3. Bastos DA, Ribeiro SC, de FD, Hoff PM (2010) Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects. Ther Adv Med Oncol 2: 261-272
4. Benson III AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van CE, Brouwers M, Charette M, Haller DG (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22: 3408-3419
5. Carrington JC, Ambros V (2003) Role of microRNAs in plant and animal development. Science 301: 336-338
6. Chan SH, Wu CW, Li AF, Chi CW, Lin WC (2008) MiR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 28: 907-911
7. Ferdin J, Kunej T, Calin GA (2010) Non-coding RNAs: identification of cancer-associated microRNAs by gene profiling. Technol Cancer Res Treat 9: 123-138
8. Figueredo A, Coombes ME, Mukherjee S (2008) Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev 3: CD005390
9. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28: 5369-5380
10. Gangadhar T, Schilsky RL (2010) Molecular markers to individualize adjuvant therapy for colon cancer. Nat Rev Clin Oncol 7: 318-325
11. Gross CP, Andersen MS, Krumholz HM, McAvay GJ, Proctor D, Tinetti ME (2006) Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA 296: 2815-2822
12. Kopetz S, Freitas D, Calabrich AF, Hoff PM (2008) Adjuvant chemotherapy for stage II colon cancer. Oncology (Williston Park) 22: 260-270
13. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773
14. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast Jr RC (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24: 5313-5327
15. Lombardi L, Morelli F, Cinieri S, Santini D, Silvestris N, Fazio N, Orlando L, Tonini G, Colucci G, Maiello E (2010) Adjuvant colon cancer chemotherapy: where we are and where we'll go. Cancer Treat Rev 36(Suppl 3): S34-S41
16. Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES (2008) Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 54: 1696-1704
17. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658
18. Nielsen BS (2012) MicroRNA in situ hybridization. Methods Mol Biol 822: 67-84
19. Nielsen BS, Jorgensen S, Fog JU, Sokilde R, Christensen IJ, Hansen U, Brunner N, Baker A, Moller S, Nielsen HJ (2011) High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 28: 27-38
20. O'Connell MJ (2004) Current status of adjuvant therapy for colorectal cancer. Oncology (Williston Park) 18: 751-755
21. O'Connor ES, Greenblatt DY, Loconte NK, Gangnon RE, Liou JI, Heise CP, Smith MA (2011) Adjuvant chemotherapy for stage ii colon cancer with poor prognostic features. J Clin Oncol 29(25): 3381-3388
22. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
23. Qian B, Katsaros D, Lu L, Preti M, Durando A, Arisio R, Mu L, Yu H (2009) High miR-21 expression in breast cancer associated with poor diseasefree survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat 117: 131-140
24. Rask L, Balslev E, Jorgensen S, Eriksen J, Flyger H, Moller S, Hogdall E, Litman T, Nielsen BS (2011) High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS 119: 663-673
25. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436
26. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402
27. Tournigand C, de Gramont A (2011) Chemotherapy: is adjuvant chemotherapy an option for stage II colon cancer? Nat Rev Clin Oncol 8: 574-576
28. Yamamichi N, Shimomura R, Inada K, Sakurai K, Haraguchi T, Ozaki Y, Fujita S, Mizutani T, Furukawa C, Fujishiro M, Ichinose M, Shiogama K, Tsutsumi Y, Omata M, Iba H (2009) Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 15: 4009-4016
29. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14: 2348-2360
30. Yao Q, Cao S, Li C, Mengesha A, Kong B, Wei M (2011) Micro-RNA-21 regulates TGF-beta-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction. Int J Cancer 128: 1783-1792